- Home
- DNLI vs DNN Comparison
DNLI vs DNN Comparison
Compare DNLI & DNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- DNN
- Stock Information
- Founded
- DNLI 2013
- DNN 1954
- Country
- DNLI United States
- DNN Canada
- Employees
- DNLI N/A
- DNN N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- DNN Other Metals and Minerals
- Sector
- DNLI Health Care
- DNN Basic Materials
- Exchange
- DNLI Nasdaq
- DNN Nasdaq
- Market Cap
- DNLI 2.2B
- DNN 1.8B
- IPO Year
- DNLI 2017
- DNN 1997
- Fundamental
- Price
- DNLI $14.85
- DNN $2.67
- Analyst Decision
- DNLI Strong Buy
- DNN
- Analyst Count
- DNLI 13
- DNN 0
- Target Price
- DNLI $32.64
- DNN N/A
- AVG Volume (30 Days)
- DNLI 1.5M
- DNN 100.5M
- Earning Date
- DNLI 11-03-2025
- DNN 11-06-2025
- Dividend Yield
- DNLI N/A
- DNN N/A
- EPS Growth
- DNLI N/A
- DNN N/A
- EPS
- DNLI N/A
- DNN N/A
- Revenue
- DNLI N/A
- DNN $3,311,190.00
- Revenue This Year
- DNLI N/A
- DNN $197.76
- Revenue Next Year
- DNLI $94,232.03
- DNN $54.87
- P/E Ratio
- DNLI N/A
- DNN N/A
- Revenue Growth
- DNLI N/A
- DNN 12.14
- 52 Week Low
- DNLI $10.57
- DNN $1.08
- 52 Week High
- DNLI $33.33
- DNN $3.42
- Technical
- Relative Strength Index (RSI)
- DNLI 42.38
- DNN 42.36
- Support Level
- DNLI $15.53
- DNN $2.70
- Resistance Level
- DNLI $17.02
- DNN $3.30
- Average True Range (ATR)
- DNLI 0.75
- DNN 0.19
- MACD
- DNLI -0.23
- DNN -0.04
- Stochastic Oscillator
- DNLI 9.18
- DNN 11.28
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.